| TAC07593 |
(2R,4R)-1-BENZYL-4-AMINO-PYRROLIDINE-2,4-DIcarboxylic acid |
|
98%+ |
| TAC06151 |
(2R,4R)-APDC |
|
98%+ |
| TAC08626 |
(2R,4S,E)-4-(2-(3,4-Dihydroxyphenethoxy)-2-oxoethyl)-3-ethylidene-2-hydroxy-3,4-dihydro-2H-pyran-5-carboxylic acid |
|
98%+ |
| TAC08739 |
(2S)-3-methyl-2-[(5R)-7-[(2-methylpropan-2-yl)oxyc |
|
98%+ |
| TAC09574 |
(2S,4R)-1-((R)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride |
|
|
| TAC07518 |
(2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide dihydrochloride |
|
98%+ |
| TAC06576 |
(2S,4R)-4-hydroxy-N-(2-hydroxy-4-(4-methylthiazol- |
|
98%+ |
| TAC00593 |
(2Z)-2-Fluorobut-2-enedioic acid |
|
98%+ |
| TAC07601 |
(3-((Cyclohexyloxy)methyl)phenyl)boronic acid |
|
98%+ |
| TAC02563 |
(3-bromopyridin-2-yl)methanol |
|
98%+ |
| TAC02686 |
(3aR,5R,6S,7R,7aR)-5-(Hydroxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]thiazole-6,7-diol |
|
98%+ |
| TAC09745 |
(3E,7E)-4,8,12-Trimethyltrideca-3,7,11-trien-1-ol |
|
98.00% |
| TAC07880 |
(3R,4R)-A2-32-01 |
|
98%+ |
| TAC01043 |
(3R,5R)-5-Methyl-pyrrolidin-3-ol hydrochloride |
|
98%+ |
| TAC01504 |
(3S,5R)-5-methylpyrrolidin-3-olhydrochloride |
|
98%+ |
| TAC08761 |
(3S,5R)-Fluvastatin sodium/XU 62-320 |
|
98%+ |
| TAC08813 |
(3S,5R)-Fluvastatin sodium/XU 62-320 |
|
98%+ |
| TAC02642 |
(4,6-Dichloropyrimidin-5-yl)methanol |
|
98%+ |
| TAC02457 |
(4-(tert-butyl)phenyl)Methanesulfonyl chloride |
|
98%+ |
| TAC01613 |
(4-bromo-2-methoxyphenoxy)-tert-butyl-diphenylsilane |
|
98%+ |
